ExpreS2ion Biotech (STO: EXPRS2)

Last close As at 05/08/2026

SEK1.34

−0.06 (−3.96%)

Market capitalisation

SEK32m

ExpreS2ion is a biotechnology company focused on the development of innovative active immunotherapies and vaccines for cancer and infectious diseases.

Latest Insights

Healthcare | Quickview

ExpreS2ion Biotech — Building the clinical data package

Market Data

Share Price SEK1.34
Market Cap SEK32m
52-Week High SEK26.45
52-Week Low SEK1.22
% Change 1M (8.6)
% Change 6M (91.0)
% Change 12M (94.9)
Ave. Daily Volume 1yr 38,725

Sector

Healthcare

Equity Analyst

Key Management

  • Bent U. Frandsen

    CEO

  • Keith Alexander

    CFO

Share Price Chart

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.